University of Kansas Cancer Center Post San Antonio Review


 

SABCS Data on mTNBC: 1L Chemo + IO in PD-L1+ Disease, Sacituzumab Govitecan, 1L AKTi + Chemo

225 views
February 28, 2021
0 Comments
Login to view comments. Click here to Login